United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congress recently, in Barcelona with its groundbreaking PET/CT, uEXPLORER. As the sponsor of “EANM Young Authors’ Award” and “EANM Technologists’ Award”, UIH takes on the responsibility as one of the major players to push forward the innovation of molecular imaging and nuclear medicine in Europe and the global stage.
At EANM Booth
EANM Congress Chair Prof. Stefano Fonti, EANM President Prof. Jolanta Kunikowska joined together with the President of International Business of UIH, Dr. Jusong Xia and UIH Europe General Manager Lukasz Mizerka, presented EANM “2022 Young Author’s Award”to this year’s winners
The world’s first total-body PET/CT, uEXPLORER is an ultra-high-resolution digital PET/CT with a 194cm axial PET field of view (FOV) that enables the entire body to be scanned in one bed position. The system offers total-body dynamic scanning, allows ultra-low patient dose, and produces ultra-high image resolution, changing how whole-body PET/CT imaging has traditionally been performed.
At the satellite symposium
“This disruptive technology is co-developed by UC Davis and UIH. As nuclear medicine and molecular imaging equipment is becoming more and more complex, we believe it is time to collaborate between industry and academia to quickly find tailored, precise solutions and bring the value of molecular imaging to oncology, cardiology and neuroscience for high quality patient care,” emphasized Prof. Li Hongdi, CTO of UIH and CEO of UIH America, at the satellite symposium.
Prof. Li Hongdi
He also announced that together with Yale University and UC Davis, UIH is working on the next-generation human brain PET scanner, the NeuroeXplorer (NX), which will lead to dramatic expansions in the study of brain diseases, such as Alzheimer’s disease and other neurological disorders.
The symposium also featured speeches from Drs. Olivari Laura, Doraku Joniada, and Giancarlo Gorgoni, Department of Nuclear Medicine and Radiometabolic Therapy IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella (VR), Hospital Negrar, Italy. As one of the most advanced centers for oncological treatment, Negrar introduced its first digital PET/CT, the uMI 780 from UIH, in June of this year.
Negrar installed its first digital PET/CT, the uMI 780 earlier this year
“Our treatment decisions are steered by the information provided by the medical device. So finding the ideal equipment was important for us, since it would be our first digital PET/CT in our center,” stressed Dr. Olivari Laura. “I remember that when we took a close look at UIH’s PET/CT, we were aware immediately that it is a machine that could change our daily practices. This PET/CT is capable of responding to any kind of radiotracer being used in clinical or research practices, which sheds lights on studies like neurodegenerative disease, inflammatory diseases, cardiovascular diseases, etc.,” added Dr. Doraku Joniada.
Dr. Doraku Joniada (Left) & Dr. Olivari Laura（Right）
UIH’s AI-enabled MI products continue to power clinical and research studies. For example, based on the digital PET/CT uMI 780, UIH partnered with Sunway Medical Centre, a well-known private hospital in Malaysia, to advance molecular imaging solutions in cancer diagnosis. BAMF Health also installed its uEXPLORER this year and completed its first total-body prostate PET. UC Davis has shown how total-body PET imaging can assess the immunological response to COVID-19 infections.
Visitors at EANM
In the past 11 years, UIH has achieved rapid growth. Fresh off the heels of its IPO, the company hit another landmark, shipping its 20,000th global installation recently.“Europe has a very mature healthcare market with fierce competition. We have put much investment in the European market. In 2019, for example, we established our subsidiary in Warsaw and now have a well-equipped local team including marketing, training, and after-sales service for hundreds of clients across Europe,” highlighted Vice President of International Business and General Manager for Europe, Lukasz Mizerka.
UIH held “The Future of Molecular Imaging” panel discussion with (From left to right) Hongdi Li of UIHA, Professors Thomas Beyer, Ph.D., MBA of the Medical University of Vienna, Akram Al-Ibraheem MD, Chairman of Nuclear Medicine Department of King Hussein Cancer Center of Jordan, Mboyo Willy Vangu of the University of Witwatersrand in Johannesburg, and Hongdi Li of UIHA, facilitated by Dr. Adam Chandler, Director of Research Collaboration
Visitors at EANM
The EANM Annual Congress is the most valuable Nuclear Medicine Meeting worldwide which aims to improve public health and promote science and education. Each year, nearly 7,000 participants and 180 companies use the possibility to discuss the newest trends and findings in the field of Nuclear Medicine.
The EANM Young Authors’ Award is offered to young investigators in the nuclear medicine field with good quality abstracts to present at the EANM Annual Congress, and encourages them to submit their clinical and scientific research results to the EANM Annual Congress. The EANM Technologists’ Award is designed to encourage young nuclear medicine technologists to present their research findings in the same event. This year, three winners are selected for EANM Young Authors’ Award, and four winners are selected for EANM Technologists’ Award. Winners of the awards receive financial support from the congress to attend the annual meetings to present their research results.